Mizuho raises Boston Scientific target to $130, maintains Outperform
Securities adjusted its outlook on Boston Scientific (NYSE:BSX) shares, raising the price target to $130 from $110 while ...
Boston Scientific price target raised to $119 from $101 at Raymond James
Raymond James raised the firm’s price target on Boston Scientific (BSX) to $119 from $101 and keeps a Strong Buy rating on the shares. Boston ...
Nasdaq1mon
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?
Boston Scientific’s BSX robust expansion of operations across different geographies outside the United States is poised to help it grow in the upcoming quarters. The company’s ...
Yahoo Finance1mon
Boston Scientific to Acquire Bolt Medical for $443 Million in Expansion of Cardiovascular Portfolio
Plans to buy Bolt Medical, Inc., a developer of intravascular lithotripsy equipment for treating hardened coronary and peripheral artery disease, were announced by Boston Scientific Corporation ...